Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi

被引:30
作者
Caston, Juan Jose
Linares, Maria Jose
Gallego, Carolina
Rivero, Antonio
Font, Pilar
Gallego, Carolina
Rivero, Antonio
Font, Pilar
Solis, Francisco
Casal, Manuel
Torre-Cisneros, Julian
机构
[1] Hosp Univ Reina Sofia, Unidad Seshou Clin Enfermedades Infecciosas, Infect Dis Unit, Cordoba 14004, Spain
[2] Reina Sofia Univ Hosp, Dept Microbiol, Cordoba, Spain
[3] Reina Sofia Univ Hosp, Dept Internal Med, Cordoba, Spain
关键词
amphotericin B; Aspergillus terreus; fungal infection; risk factor;
D O I
10.1378/chest.06-0767
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Invasive aspergillosis (U) is a common fungal infection in immunocompromised patients and has a high mortality rate. Among patients with IA, Aspergillus terreus infections have become a growing concern in the past few years. Objective: To determine the clinical risk factors for isolation of and respiratory infection by A terreus in patients with culture findings positive for filamentous fungi. Methods: Cohort study of 505 consecutive isolates of filamentous fungi in 332 patients from one center. A terreus was present in 46 isolates from 40 patients (9.1%). Clinical histories were reviewed to identify the risk factors related to isolation of and infection by A terreus, which were grouped into three categories (ie, host factors, factors related to immunosuppression, and factors related to hospitalization), and were analyzed using a multiple logistic regression model. Results: A total of 192 of 505 isolates studied (38%) were due to invasive respiratory infection. A total of 27 of 46 cultures (58.7%) that were positive for A terreus were due to invasive infection (odds ratio [OR], 2.53; 95% confidence interval [CI], 1.37 to 4.69; p = 0.034). The factors associated with invasive A terreus infection were prophylactic use of amphotericin B aerosols (OR, 27.8; 95% Cl, 6.7 to 109.7; p = 0.001) and mechanical ventilation (OR, 3.3; 95% CI, 1.02 to 10.9; p = 0.04). Transplantation was associated with a lower risk of A terreus infection (OR, 0.2; 95% CI, 0.046 to 0.789; p = 0.02). Conclusions: In patients with culture findings positive for filamentous fungi, the prophylactic use of amphotericin B aerosols and mechanical ventilation are associated with a higher risk of A terreus infections. In these patients, transplantation is associated with a lower risk of isolation and respiratory infection by A terreus.
引用
收藏
页码:230 / 236
页数:7
相关论文
共 23 条
[1]   Fungal colonization and/or infection in intensive care units.: Multicenter study of 1,562 patients [J].
Alvarez-Lerma, F ;
Palomar, M ;
León, C ;
Olaechea, P ;
Cerdá, E ;
Bermejo, B .
MEDICINA CLINICA, 2003, 121 (05) :161-166
[2]   Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: An international consensus [J].
Ascioglu, S ;
Rex, JH ;
de Pauw, B ;
Bennett, JE ;
Bille, J ;
Crokaert, F ;
Denning, DW ;
Donnelly, JP ;
Edwards, JE ;
Erjavec, Z ;
Fiere, D ;
Lortholary, O ;
Maertens, J ;
Meis, JF ;
Patterson, TF ;
Ritter, J ;
Selleslag, D ;
Shah, PM ;
Stevens, DA ;
Walsh, TJ .
CLINICAL INFECTIOUS DISEASES, 2002, 34 (01) :7-14
[3]   Epidemiology of Aspergillus terreus at a university hospital [J].
Baddley, JW ;
Pappas, PG ;
Smith, AC ;
Moser, SA .
JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (12) :5525-5529
[4]   Antifungal prophylaxis during the early postoperative period of lung transplantation [J].
Calvo, V ;
Borro, JM ;
Morales, P ;
Morcillo, A ;
Vicente, R ;
Tarrazona, V ;
París, F .
CHEST, 1999, 115 (05) :1301-1304
[5]   An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome [J].
Denning, DW ;
Marinus, A ;
Cohen, J ;
Spence, D ;
Herbrecht, R ;
Pagano, L ;
Kibbler, C ;
Kcrmery, V ;
Offner, F ;
Cordonnier, C ;
Jehn, U ;
Ellis, M ;
Collette, L ;
Sylvester, R .
JOURNAL OF INFECTION, 1998, 37 (02) :173-180
[6]  
FLYNN PM, 1993, INFECT CONT HOSP EP, V14, P363, DOI 10.1086/646761
[7]   Fluconazole and Candida krusei fungemia [J].
Girmenia, C ;
Pagano, L ;
Leone, G ;
Martino, P .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (18) :2267-2269
[8]   Aspergillus terreus - An emerging amphotericin B-resistant opportunistic mold in patients with Hematologic malignancies [J].
Hachem, RY ;
Kontoyiannis, DP ;
Boktour, MR ;
Afif, C ;
Cooksley, C ;
Bodey, GP ;
Chatzinikolaou, I ;
Perego, C ;
Kantarjian, HM ;
Raad, II .
CANCER, 2004, 101 (07) :1594-1600
[9]   Invasive pulmonary aspergillosis due to Aspergillus terreus:: 12-year experience and review of the literature [J].
Iwen, PC ;
Rupp, ME ;
Langnas, AN ;
Reed, EC ;
Hinrichs, SH .
CLINICAL INFECTIOUS DISEASES, 1998, 26 (05) :1092-1097
[10]   RISK-FACTORS FOR CANDIDEMIA IN CANCER-PATIENTS - A CASE-CONTROL STUDY [J].
KARABINIS, A ;
HILL, C ;
LECLERCQ, B ;
TANCREDE, C ;
BAUME, D ;
ANDREMONT, A .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (03) :429-432